New CBO report confirms 340B’s ballooning costs. Congress must act.

In its first report on the 340B drug discount program’s effect on the budget, the Congressional Budget Office revealed that a previously obscure federal program originally meant to help a few dozen safety-net hospitals has exploded into a multibillion-dollar subsidy for thousands of nonprofit hospitals, driving up healthcare costs for patients —  burdening taxpayers and contributing to the federal deficit — while delivering little measurable benefit to patients in need.

Read the full article at HealthCareDive.